Halozyme Therapeutics shares owned by Hantz Financial Services
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hantz Financial Services
from 13F filings
Historical chart of Hantz Financial Services investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Hantz Financial Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Hantz Financial Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.2M | 98k | 73.34 |
| 2025-06-30 | $7.0M | 135k | 52.02 |
| 2025-03-31 | $9.7M | 152k | 63.81 |
| 2024-12-31 | $6.6M | 139k | 47.81 |